mewburn-logo-white mewburn-logo
  • MyMewburn
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • MyMewburn
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
Most opposed companies at the EPO in 2024
Katherine Green - July 9, 2025

Most opposed companies at the EPO in 2024

Opposition activity at the European Patent Office is often a strong indicator of a technology’s ...

Most opposed patents of 2024
Katherine Green - June 30, 2025

Most opposed patents of 2024

The list is, again, dominated by patents for therapeutic treatments, although the trends seen last ...

New EPO sanctions against Russia
Anthony Judd - December 18, 2024

New EPO sanctions against Russia

As reported here, in late June 2024 the European Union (EU) extended their package of sanctions in ...

Claim Requests found Inadmissible in EPO Appeal Proceedings: What Can Proprietors Do?
Rebecca Tollervey - October 28, 2024

Claim Requests found Inadmissible in EPO Appeal Proceedings: What Can Proprietors Do?

Since the EPO’s Rule of Procedure of the Boards of Appeal (RPBA) were revised in 2020, parties have ...

Most opposed medical device companies at the EPO 2023
Tom Furnival - October 8, 2024

Most opposed medical device companies at the EPO 2023

Following on from our recent post on the Most Opposed Companies at the EPO 2023 we’ve broken that ...

Most opposed companies at the EPO 2023
Katherine Green - September 17, 2024

Most opposed companies at the EPO 2023

The European Patent Office grants about 100,000 patents per year (EPO Statistics here). The grant ...

Preparing your patent for success in EPO opposition proceedings
Emily Hayes - September 6, 2024

Preparing your patent for success in EPO opposition proceedings

Emily Hayes shares five simple prosecution tips to strengthen EP patents, ensuring they are in the ...

We perform significantly better than the EPO average at oppositions
Alex Galbraith - September 4, 2024

We perform significantly better than the EPO average at oppositions

We really are experts when it comes to opposing patents and our enviable success rate speaks for ...

Meet the team: Jeremy Webster, Partner, Head of Chemistry
Jeremy Webster - July 26, 2024

Meet the team: Jeremy Webster, Partner, Head of Chemistry

As part of our 'meet the team' series, we talk to partner and head of chemistry, Jeremy Webster, ...

Most opposed patents of 2023
Katherine Green - February 2, 2024

Most opposed patents of 2023

Multiple sclerosis therapies are the subject of two of the most opposed patents of 2023. Novartis’ ...

Amended Rules of Procedure of the EPO Boards of Appeal are coming into force on 1 January 2024
Emily Hayes - December 20, 2023

Amended Rules of Procedure of the EPO Boards of Appeal are coming into force on 1 January 2024

The EPO Boards of Appeal have now published their amended Rules of Procedure and these will be ...

EPO will accelerate oppositions when there are parallel UPC infringement or revocation proceedings
Lucy Coe - December 4, 2023

EPO will accelerate oppositions when there are parallel UPC infringement or revocation proceedings

The EPO have announced in the November 2023 Official Journal that they will accelerate opposition ...

Practical tips for EPO appeal proceedings under the new, stricter rules: 5 key takeaways from a recent EPO conference
Sean Constable - November 30, 2023

Practical tips for EPO appeal proceedings under the new, stricter rules: 5 key takeaways from a recent EPO conference

In 2020 the EPO revised the rules that govern the procedure at the EPO Boards of Appeal. As we ...

Most opposed patents of 2022
Katherine Green - November 13, 2023

Most opposed patents of 2022

As with CRISPR, patents directed to Nobel Prize-winning technologies are viewed as extremely ...

Meet the team: Callum McGuinn, Partner and Patent Attorney in the Chemistry team, London
Callum McGuinn - February 8, 2023

Meet the team: Callum McGuinn, Partner and Patent Attorney in the Chemistry team, London

As part of our 'meet the team' series, we talk to Callum McGuinn about his journey to becoming a ...

Meet the team: Julie Carlisle, Partner, Patent Attorney and Litigator in the Chemistry team, London
Julie Carlisle - February 5, 2023

Meet the team: Julie Carlisle, Partner, Patent Attorney and Litigator in the Chemistry team, London

As part of our 'meet the team' series, we talk to Julie Carlisle about her journey to becoming a ...

Should I file third party observations?
Emma Graham - February 1, 2023

Should I file third party observations?

A study of the consequences of filing third party observations (TPOs) in the MedTech sector and the ...

Meet the team: Eleanor Maciver, Partner and Patent Attorney in the Chemistry team, Cambridge
Eleanor Maciver - January 24, 2023

Meet the team: Eleanor Maciver, Partner and Patent Attorney in the Chemistry team, Cambridge

As part of our 'meet the team' series, we talk to Eleanor Maciver about her journey to becoming a ...

Opposition and examination oral proceedings by videoconference (ViCo) now as standard
Jonathan Wills - November 23, 2022

Opposition and examination oral proceedings by videoconference (ViCo) now as standard

In response to the significant travel restrictions that were in place across Europe during the ...

Positive feedback on oral proceedings in oppositions carried out by videoconference
Simon Kiddle - November 16, 2022

Positive feedback on oral proceedings in oppositions carried out by videoconference

In September, the EPO commissioned a survey about their opposition procedure, in particular asking ...

Meet the team: Paul Dunne, Partner and Patent Attorney in the Chemistry team, Bristol
Paul Dunne - November 1, 2022

Meet the team: Paul Dunne, Partner and Patent Attorney in the Chemistry team, Bristol

As part of our 'meet the team' series, we talk to Paul Dunne about his journey to becoming a patent ...

We perform significantly better than the EPO average at oppositions
Emily Hayes - August 5, 2022

We perform significantly better than the EPO average at oppositions

We really are experts when it comes to opposing patents and our enviable success rate speaks for ...

Most opposed patents of 2021
Katherine Green - July 28, 2022

Most opposed patents of 2021

When we reviewed our list of the most opposed European patents of 2021, we found that the patent at ...

EPO extends pilot for oral proceedings in opposition by videoconference to 31 December 2022
Emily Hayes - April 7, 2022

EPO extends pilot for oral proceedings in opposition by videoconference to 31 December 2022

On 6 April 2022, the EPO issued a notice extending its pilot project for conducting oral ...

2022 changes to EPO Guidelines: highlights
Florian Zobel - March 30, 2022

2022 changes to EPO Guidelines: highlights

With the 2021 changes to the examination guidelines, the EPO changed its schedule for issuing ...

A guide to EPO opposition proceedings by videoconference
Katherine Green - January 26, 2022

A guide to EPO opposition proceedings by videoconference

EPO oppositions by videoconference only became possible relatively recently, in April 2020. In 2021 ...

EPO extends pilot for oral proceedings in opposition by videoconference to 31 May 2022
Emily Hayes - November 24, 2021

EPO extends pilot for oral proceedings in opposition by videoconference to 31 May 2022

On 23 November 2021, the EPO issued a notice extending its pilot project for conducting oral ...

Videoconference oral proceedings: Enlarged Board of Appeal issues reasons for its decision in G 1/21
Emily Hayes - October 29, 2021

Videoconference oral proceedings: Enlarged Board of Appeal issues reasons for its decision in G 1/21

The Enlarged Board has now issued its full written decision in G 1/21 relating to videoconference ...

We helped determine the meaning of “technical feature”
Stephen Gill - May 6, 2021

We helped determine the meaning of “technical feature”

Case - T 0258/03 Our extensive arguments in relation to whether a feature is ‘technical’ have ...

Case review: what can be considered as prior art when assessing inventive step?
Matthew Naylor - May 5, 2021

Case review: what can be considered as prior art when assessing inventive step?

Case - T 0211/06 In the decision T 0211/06 from the EPO Board of Appeal (BoA), Engineering partner ...

Engineering oppositions: what is considered to be an implicit disclosure in a patent application?
Stephen Gill - May 3, 2021

Engineering oppositions: what is considered to be an implicit disclosure in a patent application?

Case - T2541/11 This decision provides guidance and clarification in three key areas of EP law:

Videoconference Oral Proceedings for EPO Oppositions – an Update
Christopher Casley - November 13, 2020

Videoconference Oral Proceedings for EPO Oppositions – an Update

The EPO has announced changes to the Pilot Project for Video Conference (ViCo) Oral Proceedings ...

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Login to MyMewburn
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy